These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38014425)

  • 1. Fat Biology in Triple-Negative Breast Cancer: Immune Regulation, Fibrosis, and Senescence.
    Lee CM; Fang S
    J Obes Metab Syndr; 2023 Dec; 32(4):312-321. PubMed ID: 38014425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-negative breast cancer and its association with obesity.
    Sun H; Zou J; Chen L; Zu X; Wen G; Zhong J
    Mol Clin Oncol; 2017 Dec; 7(6):935-942. PubMed ID: 29285353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential.
    Das K; Paul S; Ghosh A; Gupta S; Mukherjee T; Shankar P; Sharma A; Keshava S; Chauhan SC; Kashyap VK; Parashar D
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer.
    Huang R; Wang H; Hong J; Wang Z; Wu J; Huang O; He J; Chen W; Li Y; Chen X; Shen K
    Front Pharmacol; 2023; 14():1191910. PubMed ID: 37251343
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the intricate dance: Obesity and TNBC connection examined.
    Newport-Ratiu PA; Hussein KA; Carter T; Panjarian S; Jonnalagadda SC; Pandey MK
    Life Sci; 2024 Nov; 357():123082. PubMed ID: 39332488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses.
    Monaco ML; Idris OA; Essani K
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer: advancements in characterization and treatment approach.
    Hurvitz S; Mead M
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
    Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
    BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-negative breast cancer: A run-through of features, classification and current therapies.
    Manjunath M; Choudhary B
    Oncol Lett; 2021 Jul; 22(1):512. PubMed ID: 33986872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of WAVE3 as an of actin binding protein in the pathology of triple negative breast cancer.
    Master K; El Khalki L; Bayachou M; Sossey-Alaoui K
    Cytoskeleton (Hoboken); 2024 Jul; ():. PubMed ID: 39021344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
    Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies.
    Gupta GK; Collier AL; Lee D; Hoefer RA; Zheleva V; Siewertsz van Reesema LL; Tang-Tan AM; Guye ML; Chang DZ; Winston JS; Samli B; Jansen RJ; Petricoin EF; Goetz MP; Bear HD; Tang AH
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32846967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the tumor and obese microenvironment to triple negative breast cancer.
    Kaul K; Misri S; Ramaswamy B; Ganju RK
    Cancer Lett; 2021 Jul; 509():115-120. PubMed ID: 33798632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease.
    Mehlich D; Marusiak AA
    Cancer Lett; 2022 Oct; 547():215775. PubMed ID: 35667515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
    Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CSC in a Most Aggressive Subtype of Breast Cancer TNBC.
    Bao B; Prasad AS
    Adv Exp Med Biol; 2019; 1152():311-334. PubMed ID: 31456192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.